TRANSTHERA-B has been included in the Hang Seng Index series constituents

Zhitong
2025.08.25 14:37
portai
I'm PortAI, I can summarize articles.

TRANSTHERA-B announced that it will be included in the Hang Seng Index series constituents starting from September 8, 2025, including the Hang Seng Composite Index and several healthcare-related indices. This decision reflects the increasing recognition of the company by investors

According to the announcement from WuXi AppTec-B (02617), the company has been selected to be included in the Hang Seng Index series components, effective from September 8, 2025, based on the quarterly review results announced by Hang Seng Indexes Company Limited on August 22, 2025. The indices include but are not limited to the following:

  1. Hang Seng Composite Index;

  2. Hang Seng Composite Industry Index - Healthcare;

  3. Hang Seng Composite Small and Mid-Cap Index;

  4. Hang Seng Composite Small Cap Index;

  5. Hang Seng Healthcare Index;

  6. Hang Seng Innovative Drug Index;

  7. Hang Seng Stock Connect Innovative Drug Index;

  8. Hang Seng Stock Connect Innovative Drug Select Index; and

  9. Hang Seng Stock Connect Pharmaceuticals and Biotechnology (Investable) Index.

The announcement stated that the inclusion of the company in the Hang Seng Composite Index and the above indices reflects an increase in investor recognition

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.